Elucidating mechanisms which modulate PDGFRβ signaling will give a greater understanding of the process of vascular smooth muscle remodeling in the context of cardiovascular disease, and possibly other PDGFR signaling-driven processes such as cancer and pulmonary fibrosis. Here, PDGFRB is linked to cardiovascular disorder.